期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Expert Opinion on Drug Delivery LetPub Score 7.6
50 ratings
Rate
Reputation 8.8 Influence 6.4 Speed 9.0 | ||||||||||||||||
期刊簡稱 | EXPERT OPIN DRUG DEL | ||||||||||||||||
ISSN | 1742-5247 | ||||||||||||||||
h-index | 88 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 4.00%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.tandfonline.com/loi/iedd20 | ||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/eodd | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Taylor and Francis Ltd. | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||
創刊年 | 2004 | ||||||||||||||||
每年文章數 | 103每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 15.75% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1742-5247%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Expert Opinion on Drug Delivery] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:07:59 評論於 3-5 recommended journals(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:04:52 評論於 Authors should first search and analyze in SCI and Scopus databases. Secondly, they need to carefully read the submission guidelines of the journal they are preparing to submit to, and review the recent issues and related articles of the journal to confirm if their manuscript aligns with the journal's content(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 13:23:41 評論於 How to evaluate the impact factor of your own article, or how to better position your article?(0) 讚! | 平原文波 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 11:32:45 評論於 How many suitable options are selected when selecting the periodical?(0) 讚! | 北国博达 |
作者: 巴蜀清雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-21 23:43:25 評論於 Review speed: 4.0 Experience sharing: What to do if the link to the editor's reply cannot be opened Expert opinion on drug delivery(0) 讚! | 巴蜀清雅 |
作者: 碧桃逸致 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-21 16:27:46 評論於 Review speed: 4.0 Experience sharing: What to do if the URL of the editor's response cannot be opened Expert opinion on drug delivery(0) 讚! | 碧桃逸致 |
作者: 193291787@qq.com 領域: 医药科学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-04-21 10:23:29 評論於 Edit reply URL can not open,How to do expert opinion on drug delivery(0) 讚! | 193291787@qq.com |
作者: 193291787@qq.com 領域: 医药科学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-04-21 10:23:21 評論於 Edit reply reply URL can not open, how to do expert opinion on drug delivery(0) 讚! | 193291787@qq.com |
作者: 亚当威尔斯 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-13 12:39:37 評論於 Review speed: 2.0 Experience sharing: It took two months to receive a response after submitting the manuscript, and it was still not sent for review. The wait for editor processing also took another two months. The journal mainly publishes review articles. I am not sure if the delay is due to the fact that my article is original research. However, the editor processing is also too slow(0) 讚! | 亚当威尔斯 |
作者: 479152268@qq.com 領域: 医药科学 審稿時間: 2.0 month(s) 結果: 拒稿 撰寫評論 |
2018-04-13 09:46:28 評論於 I received the results two months after submission. It was not sent to peer review, so it took two months just waiting for the editorial processing. The journal publishes review articles; I don't know if this is the reason why it took so long. But the editing process is too slow. (0) 讚! | 479152268@qq.com |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 11:05:03 評論於 It's still just above average, although there hasn't been much change, being able to stay stable is considered above average(0) 讚! | 凌霄高洁 |
作者: 金刚爱鹏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-02-01 22:22:23 評論於 Hello, I would like to ask for expert opinion on drug delivery. After submission and successful acceptance, the status is Awaiting Commissioning Editor Processing, and the system sends an email with a PDF attachment, stating "If you have not already done so, please complete and return the attached disclosure form." It then asks to choose the reviewing method and if there is a need for acceleration. Do I need to reply?(0) 讚! | 金刚爱鹏 |
作者: 法慧和同 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-09-01 23:41:00 評論於 Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: Quite difficult, revised many times, also requires high research completeness(0) 讚! | 法慧和同 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 12:51:19 評論於 Bullish, will it rise again next year?(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us